Dual-center retrospective cohort analysis of high-risk cutaneous squamous cell carcinoma tumors
Archives of Dermatological Research · 2025
DOI: 10.1007/s00403-024-03712-8 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Brandon Calley und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Medical College of Wisconsin, 8701 W. Watertown Plank Road, Milwaukee, WI, 53226, USA. Hauptthemen laut MEDLINE: Skin Neoplasms, Carcinoma, Squamous Cell, Neoplasm Recurrence, Local. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
High-risk cutaneous squamous cell carcinoma (hr-cSCC) tumors exhibit aggressive behavior, leading to local recurrence, metastasis, and mortality. The management of hr-cSCC tumors is not well-defined. To clarify the impact of clinical risk factors and management strategies on disease-related outcomes (DROs) in patients with hr-cSCCs. This dual-center retrospective cohort study reviewed patient records from 2007 to 2023, focusing on hr-cSCC tumors classified as high-risk according to two staging systems. 160 adult patients with hr-cSCC were included. Tumors > 2 cm were associated with a higher risk of recurrence, metastasis, and mortality, with greater risk for tumors > 4 cm. Nonsurgical therapies were linked to higher recurrence and mortality rates compared to surgical monotherapy. Patients whose initial treatment was delayed > 60 days following biopsy had increased incidence of DROs. Other variables associated with at least one DRO included female sex, higher tumor grade, lymphovascular invasion, and advanced AJCC-8 stages. Limitations of this study include its retrospective design, narrow demographics, and variable follow-up times. This study identifies increased tumor diameter, non-surgical treatments, delayed treatment > 60 days after biopsy, female sex, tumor grade, lymphovascular invasion, and advanced tumor stage as significant risk factors for DROs in hr-cSCC. Importantly, our study provides new clarifying evidence that delayed surgical treatment of hr-cSCCs > 60 days after biopsy is associated with elevated incidence of DROs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Medical College of Wisconsin, 8701 W. Watertown Plank Road, Milwaukee, WI, 53226, USA.
- Department of Biostatistics, Medical College of Wisconsin, 8701 W. Watertown Plank Road, Milwaukee, WI, 53226, USA.
- Department of Dermatology, Medical College of Wisconsin, 8701 W. Watertown Plank Road, Milwaukee, WI, 53226, USA. mclark@mcw.edu.
Zitieren
APA
Calley, B., Trieglaff, K., Boswell, N., Vu, A., Popatia, S., Rivera, D. B., Tsafack, U. K., Banerjee, A., Vaughn, O. A., & Clark, M. A. (2025). Dual-center retrospective cohort analysis of high-risk cutaneous squamous cell carcinoma tumors. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03712-8
Vancouver
Calley B, Trieglaff K, Boswell N, Vu A, Popatia S, Rivera DB, et al. Dual-center retrospective cohort analysis of high-risk cutaneous squamous cell carcinoma tumors. Archives of Dermatological Research. 2025. doi:10.1007/s00403-024-03712-8
BibTeX
@article{Calley2025,
author = {Calley, Brandon and Trieglaff, Kendall and Boswell, Nicole and Vu, Alan and Popatia, Sabrina and Rivera, Daniel Benitez and Tsafack, Ulrich Kemmo and Banerjee, Anjishnu and Vaughn, Olushola Akinshemoyin and Clark, Melanie A},
title = {Dual-center retrospective cohort analysis of high-risk cutaneous squamous cell carcinoma tumors},
journal = {Archives of Dermatological Research},
year = {2025},
doi = {10.1007/s00403-024-03712-8}
}
EUVIMED